This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Elsevier Announces The Launch Of A New Journal: "Health Care: The Journal Of Delivery Science And Innovation"

NEW YORK, November 12, 2012 /PRNewswire/ --

Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the launch of  Health Care: The Journal of Delivery Science and Innovation.

Health Care provides a vehicle for communicating important advances in the study of cutting edge research on innovation in health care delivery, including improvements in systems, processes, management, payment, and applied information technology. The United States health care system is undergoing unprecedented reform; Health Care builds on examples to demonstrate how change happens in real-world settings, disseminating important ideas that inform and improve clinical practice by publishing innovative, high-quality research, reviews and opinions.

The leadership of the journal comes under three Senior co-Editors-in-Chief, all renowned experts on health care transformation: Arnold Milstein, Professor of Medicine at Stanford and Medical Director of the Pacific Business Group on Health; Richard Shannon, the Frank Wister Professor of Medicine and Chair of the Department of Medicine at the University of Pennsylvania; and Ashish Jha, C. Boden Gray Associate Professor of Medicine at the Harvard School of Public Health.

"This is a critical time for the U.S. health care system," said Dr. Jha. "The need for thoughtful, high-quality empirical work to guide us has never been greater. Health Care will combine data-driven evaluations of current efforts with insightful commentary from the most innovative thinkers in the U.S.  We aim to make it an important force for fresh ideas on how to improve the healthcare delivery system."

Founders of the journal and co-Editors-in-Chief are Amol Navathe, MD, PhD, a physician at the Brigham and Women's Hospital who holds appointments at Harvard Medical School and The Wharton School of the University of Pennsylvania, and Sachin H. Jain, MD, MBA, a physician at the Boston Veteran's Administration Medical Center, Lecturer in Health Care Policy at Harvard Medical School, and Chief Medical Information and Innovation Officer at Merck.

Christine Cassel, the President of the American Board of Internal Medicine and a member of the journal's editorial board, stated, "Health care delivery systems are advancing at an incredible pace. Physicians and other members of the health care team need help in translating these changes in health care delivery into broader practice. This new launch will provide the community with a high-quality journal in which to publish these advances and drive change." 

"Elsevier is pleased to work with the distinguished leadership of this journal to publish scholarly communication at the nexus of healthcare and technology," said Ann Gabriel, Publishing Director at Elsevier. "The launch of this journal is very timely given the rapidly evolving landscape of health care delivery in the U.S."

For more information or to submit an article, go to Health Care: The Journal of Delivery Science and Innovation  http://www.elsevier.com/locate/healthcare

About Elsevier

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,960.57 -123.23 -0.72%
S&P 500 1,978.34 -9.64 -0.48%
NASDAQ 4,449.5640 -22.5440 -0.50%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs